Gayle Lewis has been an employee of McMaster University for 26 years. In December 1989 she joined the Clinical Epidemiology & Biostatistics Group (CE&B) under the direction of Ms. Roberta Labelle. She remained on campus until July 1992, when she relocated to the Clinical Trials Methodology Group (CTMG) at the now Juravinski Hospital, under the direction of Prof. Michael Gent and Mr. Harvey Nelson. She remained there until October 2005 when she joined the PHRI Arrhythmia group to work on the RELY trial. In March 2007, she started up the AVERROES trial and managed all trial activities until study closure in December 2010. Her involvement in various other trials (AVERROES LTOLE and KT-INR) continued until her move to Global Health in September 2012. Within Global Health, she continues to work on various epidemiological studies including PURE and a new randomized clinical trial, INVICTUS.
Prior to joining McMaster, she worked in Toronto at Digital Equipment of Canada for 5 years and was responsible for the development, testing, implementation and training of the Canadian Automatic Quoting system (AQS) for all Sales Representatives across Canada.